Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

Completed · Phase 2

Conditions studied: Anovulation

In brief

The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor (anastrozole) versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction.

Key facts

Study ID

NCT00213148

Run by

EMD Serono

People needed

271

Starts

2005-03-10

Expected to finish

2007-12-12

Last updated by the study team

2018-07-17

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18-40 years
• Ovulatory dysfunction characterized by irregular and/or extended cycles
• Non-smoker

You may not qualify if…

• No previous gonadotropin treatment
• No more than 6 previous clomiphene treatment cycles

Where it is running

• Local US Medical Information — Rockland, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.